Additional Proxy Soliciting Materials (definitive) (defa14a)
June 14 2021 - 9:00AM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES AND EXCHANGE COMMISSION
Washington,
D.C. 20549
SCHEDULE
14A
Proxy
Statement Pursuant to Section 14(a) of
the Securities Exchange Act of 1934 (Amendment No. )
Filed
by the Registrant [X]
Filed
by a Party other than the Registrant [ ]
Check
the appropriate box:
[ ]
|
Preliminary
Proxy Statement
|
[ ]
|
Confidential,
for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
[ ]
|
Definitive
Proxy Statement
|
[X]
|
Definitive
Additional Materials
|
[ ]
|
Soliciting
Material under §240.14a-12
|
SONNET
BIOTHERAPEUTICS HOLDINGS, INC.
|
(Name
of Registrant as Specified In Its Charter)
|
|
|
(Name
of Person(s) Filing Proxy Statement, if other than the Registrant)
|
Payment
of Filing Fee (Check the appropriate box):
|
|
[X]
|
No
fee required.
|
[ ]
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title
of each class of securities to which transaction applies:
|
|
|
|
|
(2)
|
Aggregate
number of securities to which transaction applies:
|
|
|
|
|
(3)
|
Per
unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the
filing fee is calculated and state how it was determined):
|
|
|
|
|
(4)
|
Proposed
maximum aggregate value of transaction:
|
|
|
|
|
(5)
|
Total
fee paid:
|
|
|
|
[ ]
|
Fee
paid previously with preliminary materials.
|
[ ]
|
Check
box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its
filing.
|
|
(1)
|
Amount
Previously Paid:
|
|
|
|
|
(2)
|
Form,
Schedule or Registration Statement No.:
|
|
|
|
|
(3)
|
Filing
Party:
|
|
|
|
|
(4)
|
Date
Filed:
|
|
|
|
EXPLANATORY
NOTE
The
purpose of this Schedule 14A is to file a letter from Sonnet BioTherapeutics Holdings, Inc. that will be delivered to its stockholders
beginning on June 14, 2021 advising them of a change in date of the annual meeting of stockholders.
SONNET
BIOTHERAPEUTICS HOLDINGS, INC.
100
Overlook Center, Suite 102
Princeton,
New Jersey 08540
NOTICE
OF DATE CHANGE FOR THE
ANNUAL MEETING OF STOCKHOLDERS TO THURSDAY JULY 15, 2021
To
the Stockholders of Sonnet BioTherapeutics Holdings, Inc.:
Sonnet
BioTherapeutics Holdings, Inc. (“Sonnet”) has changed the date of its upcoming annual meeting of stockholders (the “Annual
Meeting”) called for the purpose of approving certain proposals, including the election of directors and the ratification of the
appointment of Sonnet’s independent auditing firm for the fiscal year ended September 30, 2021, from June 24, 2021 to Thursday
July 15, 2021 at 9:00 a.m., Eastern Time, to be held virtually via the Internet at https://stctransfer.zoom.us/webinar/register/WN_nRBjkIpOTqSbSyBqXlnDjQ.
There
is no change to the proposals to be presented to our stockholders for consideration at the Annual Meeting.
Our
proxy materials including our Proxy Statement for the Annual Meeting, our annual report for the fiscal year ended September 30, 2020
and proxy card are available on the Internet at http://onlineproxyvote.com/SONN.
Your
continuing interest in Sonnet is very much appreciated.
|
Sincerely,
|
|
|
|
/s/
Pankaj Mohan, Ph.D.
|
|
Pankaj
Mohan, Ph.D.
|
|
Chief
Executive Officer and Chairman of the Board
|
Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
From Apr 2023 to Apr 2024